Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About IAI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Infection and Immunity
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About IAI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Host Response and Inflammation

Virulence and Immune Response Induced by Mycobacterium avium Complex Strains in a Model of Progressive Pulmonary Tuberculosis and Subcutaneous Infection in BALB/c Mice

Mónica González-Pérez, Leonardo Mariño-Ramírez, Carlos Alberto Parra-López, Martha Isabel Murcia, Brenda Marquina, Dulce Mata-Espinoza, Yadira Rodriguez-Míguez, Guillermina J. Baay-Guzman, Sara Huerta-Yepez, Rogelio Hernandez-Pando
J. L. Flynn, Editor
Mónica González-Pérez
aDepartment of Microbiology, Medicine School, National University of Colombia, Bogotá, Colombia
bExperimental Pathology Section, Department of Pathology, National Institute of Medical Sciences and Nutrition, Salvador Zubirán, Mexico City, Mexico
dPanAmerican Bioinformatics Institute, Santa Marta, Magdalena, Colombia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Leonardo Mariño-Ramírez
aDepartment of Microbiology, Medicine School, National University of Colombia, Bogotá, Colombia
cComputational Biology Branch, National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, Maryland, USA
dPanAmerican Bioinformatics Institute, Santa Marta, Magdalena, Colombia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carlos Alberto Parra-López
aDepartment of Microbiology, Medicine School, National University of Colombia, Bogotá, Colombia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martha Isabel Murcia
aDepartment of Microbiology, Medicine School, National University of Colombia, Bogotá, Colombia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brenda Marquina
bExperimental Pathology Section, Department of Pathology, National Institute of Medical Sciences and Nutrition, Salvador Zubirán, Mexico City, Mexico
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dulce Mata-Espinoza
bExperimental Pathology Section, Department of Pathology, National Institute of Medical Sciences and Nutrition, Salvador Zubirán, Mexico City, Mexico
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yadira Rodriguez-Míguez
bExperimental Pathology Section, Department of Pathology, National Institute of Medical Sciences and Nutrition, Salvador Zubirán, Mexico City, Mexico
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Guillermina J. Baay-Guzman
eResearch Unit of Oncology, Pediatrics Hospital of Mexico Federico Gomez, Mexico City, Mexico
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sara Huerta-Yepez
eResearch Unit of Oncology, Pediatrics Hospital of Mexico Federico Gomez, Mexico City, Mexico
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rogelio Hernandez-Pando
bExperimental Pathology Section, Department of Pathology, National Institute of Medical Sciences and Nutrition, Salvador Zubirán, Mexico City, Mexico
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. L. Flynn
Roles: Editor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/IAI.00150-13
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

The genus Mycobacterium comprises more than 150 species, including important pathogens for humans which cause major public health problems. The vast majority of efforts to understand the genus have been addressed in studies with Mycobacterium tuberculosis. The biological differentiation between M. tuberculosis and nontuberculous mycobacteria (NTM) is important because there are distinctions in the sources of infection, treatments, and the course of disease. Likewise, the importance of studying NTM is not only due to its clinical significance but also due to the mechanisms by which some species are pathogenic while others are not. Mycobacterium avium complex (MAC) is the most important group of NTM opportunistic pathogens, since it is the second largest medical complex in the genus after the M. tuberculosis complex. Here, we evaluated the virulence and immune response of M. avium subsp. avium and Mycobacterium colombiense, using experimental models of progressive pulmonary tuberculosis and subcutaneous infection in BALB/c mice. Mice infected intratracheally with a high dose of MAC strains showed high expression of tumor necrosis factor alpha (TNF-α) and inducible nitric oxide synthase with rapid bacillus elimination and numerous granulomas, but without lung consolidation during late infection in coexistence with high expression of anti-inflammatory cytokines. In contrast, subcutaneous infection showed high production of the proinflammatory cytokines TNF-α and gamma interferon with relatively low production of anti-inflammatory cytokines such as interleukin-10 (IL-10) or IL-4, which efficiently eliminate the bacilli but maintain extensive inflammation and fibrosis. Thus, MAC infection evokes different immune and inflammatory responses depending on the MAC species and affected tissue.

INTRODUCTION

Although the genus Mycobacterium was described over a century ago (1, 2), the main research focus has been on Mycobacterium tuberculosis, currently considered the most important human bacterial pathogen. Indeed, tuberculosis (TB) is the worldwide leading cause of death produced by bacterial disease and is one of the most important challenges to public health (3–5). However, there are a large number of species known as atypical or nontuberculous mycobacteria (NTM) (6), which include nearly 140 species (1, 2) and although they are not considered a public health problem, their importance is increasing due to their frequent association with immunosuppression, especially in HIV/AIDS patients, which is highly fatal (7–11). Diseases caused by NTM are known collectively as mycobacteriosis, and the symptoms include lung infection, lymphadenitis, soft tissue or skin lesions, and even disseminated disease (12).

The biological differentiation between M. tuberculosis and NTM is important because it implies fundamental differences in the source of infection, treatment, and the course of the disease. Likewise, the importance of studying NTM is not only because of its clinical relevance but also because of the involved mechanisms by which some species of the genus are pathogenic while others are not. Although the epidemiology of TB has been extensively studied, the incidence worldwide and the prevalence of mycobacteriosis remains poorly understood, partly due to the fact that NTM diseases are not usually reported to public health centers. Mycobacteriosis estimates are based on occasional laboratory isolates and, in most cases, are suspected of being caused by M. tuberculosis (13–15). In addition, because the vast majority of the NTM are naturally resistant to drugs used against M. tuberculosis (12), it is not unusual that they are being wrongly identified and reported as multidrug-resistant M. tuberculosis strains (16, 17).

Mycobacterium avium complex (MAC) contains clinically important NTM worldwide and is the second largest medical complex in the Mycobacterium genus after the M. tuberculosis complex. MAC strains are frequently isolated worldwide, and currently M. tuberculosis and MAC are the mycobacterial species that require the biggest efforts in care and treatment within the genus (12, 14, 18–20). MAC affects patients with chronic obstructive pulmonary disease, cystic fibrosis, and mainly immunosuppressed individuals with HIV/AIDS (21, 22). MAC is composed of a number of different serovars, strains, subspecies, and morphological forms that differ in virulence (21, 22, 27). MAC is considered the leading cause of highly fatal systemic bacterial infection that affects 40% of patients with HIV/AIDS and is the most common NTM pathogen group in the United States (12, 23). In most cases, it is not known which of the MAC species is the pathogen and, unlike the person-person transmission of M. tuberculosis, MAC transmission appears to occur from an environmental source (6, 24). M. avium is the most widely studied MAC species, is frequently isolated from drinking water, and could be the main source of infection for immunosuppressed individuals (25). Instead, pulmonary disease is the most common manifestation in immunocompetent individuals (26), whereas AIDS patients frequently present with a generalized infection (27).

Mycobacterium colombiense is a MAC species that was isolated from the sputum and blood of HIV/AIDS Colombian patients (28); this strain produced lymphadenopathy in immunocompetent children from France and Spain (29, 30) and was associated with pulmonary infections that complicated cases of cystic fibrosis (31). Therefore, this group of opportunistic pathogens have virulence mechanisms that allow them to adapt, survive, replicate, and produce disease in the host. However, the virulence and immune response evoked in vivo by members of these species has not been evaluated. The aim of the present study was to evaluate the virulence and immune response evoked by two MAC species (M. avium subsp. avium and M. colombiense) using experimental models of progressive pulmonary TB and subcutaneous infection in BALB/c mice.

MATERIALS AND METHODS

Selection of study strains.We used two different and well-characterized MAC species from the Spanish Type Culture Collection (CECT); M. colombiense CECT 3035 and M. avium subsp. avium CECT 7407. M. tuberculosis H37Rv (American Type Culture Collection [ATCC] 25618) was used as a control for comparison. Bacteria were grown in Middlebrook 7H9 broth (BD Difco) enriched with glycerol and albumin, catalase, and dextrose (Middlebrook ADC; BD Difco), in constant agitation at 37°C and 5% CO2 during 21 days for M. tuberculosis H37Rv and 15 days for MAC. The stock cultures were stored at −70°C in 50% glycerol until use.

Experimental model of progressive pulmonary TB in BALB/c mice.Virulence (as determined by survival, pulmonary histopathology, and bacterial load) and immune response induced by each isolate were evaluated in 8-week-old male BALB/c mice as previously described (32–35). Briefly, bacteria were grown as described above and, as soon as the culture reached the log phase, the bacilli were harvested, and the concentration was adjusted to 2.5 × 105 viable bacilli per 100 μl of phosphate-buffered saline (PBS), as determined by fluorescein diacetate (Sigma-Aldrich) incorporation. Progressive pulmonary TB induction was performed as follows: mice were anesthetized with sevoflurane vapors and inoculated intratracheally using a sterile cannula (Thomas Scientific, catalog no. 1121A12, straight, 22G×1″), with 2.5 × 105 bacilli in 100 μl of PBS. Infected mice were kept in a vertical position until the effect of anesthesia passed. Two independent experiments were performed; in each experiment three groups of 50 mice were infected with either MAC species or H37Rv, and 10 mice more from each group were left undisturbed to record survival from day 1 up to day 120 after infection. Six animals from each group were sacrificed by exsanguination at 1, 3, 7, 14, 21, 28, 60, and 120 days after infection. One lung lobe, right or left, was perfused with ethanol and prepared for histopathological studies. The other lobe and other samples (whole blood, spleen, and mediastinal lymph nodes) were snap-frozen in liquid nitrogen and stored at −70°C for microbiological and immunological analyses. Infected mice were kept in cages fitted with microisolators connected to negative pressure. All procedures were performed in a class III cabinet in a biosafety level III facility according to the guidelines and approval by the Animal Experimentation Ethics Committee of the National Institute of Medical Sciences and Nutrition of Mexico.

Experimental model of subcutaneous infection in BALB/c mice.The experimental model was set up in 6- to 8-week-old male BALB/c mice. Bacteria were grown as described above and, as soon as the culture reached log phase, the bacilli were harvested, and the concentration was adjusted to 2.5 × 105 viable bacilli per 100 μl of PBS, as determined by diacetate of fluorescein incorporation (Sigma-Aldrich). As reported previously (36), groups of 50 animals were inoculated subcutaneously with 2.5 × 105 bacilli suspended in 40 μl of PBS for each individual strain utilizing a sterile syringe and needle in each footpad, and 10 mice from each group were left undisturbed to record survival from day 1 up to day 120 after infection. Three animals from each group were sacrificed by exsanguination at 3, 14, 21, 28, 60, and 120 days after infection. One footpad, right or left, was prepared for histopathological studies, and the other footpad was snap-frozen in liquid nitrogen and stored at −70°C for microbiological and immunological analysis. Infected mice were kept in cages fitted with microisolators connected to negative pressure.

Tissue preparation for histology and automated morphometry.One lung lobe from each mouse was fixed by intratracheal perfusion with 10% formaldehyde dissolved in PBS for 24 h and then sectioned through the hilus and embedded in paraffin. Sections, 5 μm thick, were stained with hematoxylin and eosin for the histological and morphometric analysis using an automated image analyzer (Carl Zeiss, Ltd., Herts, United Kingdom) as previously described (33).

Regarding the subcutaneous tissue analysis, one footpad from each of the three mice per time point was obtained, immediately fixed by immersion in 10% formaldehyde dissolved in PBS during 24 h, and then sectioned longitudinally and embedded in paraffin. Tissue sections were stained with hematoxylin and eosin and analyzed.

Determination of CFU in infected tissues.Right or left lung lobes, whole blood, mediastinal lymph nodes, and spleens from three mice at each time point and in two independent experiments were used for CFU counting. The tissues were homogenized with a Polytron (PT 3100-Laboratoryhomogenizer; Kinematica Dispersing and Mixing Technology) in sterile 50-ml tubes containing 1 ml of PBS–1× Tween 80 (0.05%). Three dilutions of each homogenate were spread onto duplicate plates containing Middlebrook 7H10 agar (BD Difco) enriched with glycerol, albumin, oleic acid, dextrose, and catalase (Middlebrook OADC; BD Difco). Colonies were counted twice under a stereoscopic microscope (STEMI 2000 MICR-PA 085; Carl Zeiss) after 21 days of incubation for M. tuberculosis H37Rv and 15 days for MAC (33).

Three footpads, right or left, collected from infected and control mice at each time point were used for colony counting. Tissues were ground with a mortar and then homogenized with a Polytron; dilutions of each homogenate were spread, incubated, and counted as described above.

Kinetics of cytokines gene expression determined by real-time PCR in tissue homogenates.Right or left lung lobes and footpads from three different mice per group were used to isolate total RNA using an RNeasy minikit (Qiagen Sample & Assay Technologies) according to the manufacturer's recommendations. Total RNA quality and quantity were evaluated through spectrophotometry (using a 260/280 absorbance ratio) and on agarose gels. Reverse transcription was performed using Omniscript reverse transcriptase (Qiagen) from 100 ng of total RNA, 150 μg of Oligo(dT) 15 primer (Promega Corp.)/ml, 10 U of RNase inhibitor (Invitrogen/Life Technologies), 1× reverse transcriptase buffer, 0.5 mM concentrations of each deoxynucleoside triphosphate, and 4 U of Omniscript reverse transcriptase. Real-time PCR was performed using the 7500 real-time PCR system (Applied Biosystems) and a QuantiTect SYBR green PCR kit (Qiagen). Standard curves of quantified and diluted PCR product, as well as negative controls, were included in each PCR run. Specific primers were used for the following targets: GAPDH (glyceraldehyde-3-phosphate dehydrogenase), 5′-CATTGTGGAAGGGTCCATGA-3′ and 5′-GGAAGGCCATGCCAGTGAGC-3′; tumor necrosis factor alpha (TNF-α), 5′-TGTGGCTTCGACCTCTACCTC-3′ and 5′-GCCGAGAAAGGCTGCTTG-3′; gamma interferon (IFN-γ), 5′-CCTCAAACTTGGCAATACTCAT-3′ and 5′-GGTGACATGAAAATCCTGCAG-3′; inducible nitric oxide synthase (iNOS), 5′-CATTTCGCTGTCTCCCCAA-3′ and 5′-AGCGAGGAGCAGGTGGAAG-3′; interleukin-4 (IL-4), 5′-CGTCCTCACAGCAACGGAGA-3′ and 5′-GCAGCTTATCGATGAATCCAGG-3′; transforming growth factor (TGF), 5′-AGGGCTACCATGCCAACTTCT-3′ and 5′-CCGGGTTGTGTTGGTTGTACA-3′; and IL-10, 5′-AAAGGCACTGCACGACATAGC-3′ and 5′-TGCGGAGAACGTGGAAAAAC-3′. The cycling conditions were as follows: initial denaturation at 95°C for 10 min, followed by 40 cycles at 95 for 20 s, 58 to 60°C for 20 s, and 72°C for 35 s. Quantities of the specific mRNA in the sample were measured according to the corresponding gene-specific standard. The mRNA copy number of each cytokine was related to one million copies of mRNA encoding the GAPDH gene (37). H37Rv was used as a control for all experiments in the BALB/c model.

Cytokine production determined by immunohistochemistry and digital automated morphometry.The same paraffin-embedded material prepared for histopathological studies was used to determine the local cytokine production by immunohistochemistry. Lung and footpad sections from mice infected with either MAC or M. tuberculosis H37Rv strain, obtained at early (day 21) and late (day 120) infection, were deparaffinized and maintained in 1× HCN buffer (HEPES, NaCl, and CaCl2). Sections were washed with 1× HCN plus 0.05% Tween 20, and the endogenous peroxidase activity was blocked with 6% H2O2 dissolved in 1× PBS plus 0.1% sodium azide, followed by incubation for 1 h. After blocking with normal swine serum, tissue sections were incubated with primary antibodies overnight at 4°C at optimal dilutions, which had been determined previously. We used primary antibodies against TNF-α (rabbit polyclonal IgG clone H-156; Santa Cruz Biotechnology), IFN-γ (goat polyclonal IgG clone D-17; Santa Cruz Biotechnology), IL-4 (goat polyclonal IgG; Santa Cruz Biotechnology), and IL-10 (goat polyclonal IgG clone M-18; Santa Cruz Biotechnology). Secondary biotinylated antibodies (biotin–anti-rabbit IgG or biotin–anti-goat IgG) were used to detect the binding of the primary antibodies. Finally, horseradish peroxidase-conjugated avidin and 3,3-diaminobenzidine–hydrogen peroxide were used to develop the reaction. Tissue sections were counterstained with hematoxylin.

For digital automated morphometry, slides were scanned for each strain and tissue using an Aperio ScanScope (Aperio Technologies, Vista, CA). After saving each digital image, all of the lung area or the footpad inflammatory infiltrate were selected for analysis. Aperio ImageScope software (Aperio) was used with the application of the Aperio Pixel Count v9 algorithm, which is based on the spectral differentiation between brown (positive) and blue (counter) staining and provide a number of 1+, 2+, and 3+ intensity positive pixels, a mean of intensity was determined from each slide that corresponded to the estimated concentration of each selected cytokine.

Statistical analysis.Two-way analysis of variance was used to determine the statistical significance of CFU and cytokines. A P value of <0.05 was considered significant.

RESULTS

Survival, histopathology, and bacillary loads in mice infected by the intratracheal route.In order to characterize the M. avium and M. colombiense virulence in the model of pulmonary TB, groups of BALB/c mice were infected intratracheally with 2.5 × 105 bacilli of either MAC species or M. tuberculosis H37Rv strain as a comparative control. All of the animals infected with M. avium or M. colombiense survived after 4 months of infection. In contrast, mice inoculated with M. tuberculosis started to die at 8 weeks postinfection, and 50% survived after 120 days of infection (data not shown). These survival rates associated well with the CFU quantifications in lung homogenates where, by the third week postinfection, a lower bacterial load was found in mice infected with M. colombiense even though similar numbers of CFU had been detected in the three groups during the first week of infection (Fig. 1A). In comparison to animals infected with M. tuberculosis, at days 21, 28, and 60 postinfection, significantly lower bacterial loads were found in the lungs of mice infected with M. colombiense or M. avium, being fewer in the former, while at day 120 almost undetectable live bacilli were observed in animals infected with either MAC species. In contrast, a progressive increase of bacillus loads in the lung was seen in mice infected with M. tuberculosis, raising its peak at day 120 postinfection (Fig. 1A). In blood, after 3 days of infection, mice infected with either MAC species showed a progressive increase of the bacillus load for 2 weeks, followed by a transient decrease by days 21 and 28 postinfection and a new increase at day 60 postinfection. At almost all of these time points, the bacillus loads in blood from mice infected with M. avium or M. colombiense were significantly higher than in mice infected with M. tuberculosis (Fig. 1B). A similar trend was observed in spleens and mediastinal lymph nodes (Fig. 1C and D, respectively), where, after the first week during late infection at days 60 and 120, higher bacillus loads were determined in animals infected with MAC strains than with M. tuberculosis.

Fig 1
  • Open in new tab
  • Download powerpoint
Fig 1

Lung bacillus loads in BALB/c mice infected by intratracheal injection. Mice were infected with M. colombiense (grey), M. avium (white), or M. tuberculosis strain H37Rv (black) and euthanized at different time points after infection, and the indicated organs were used to determine the number of CFU. Asterisks represent statistical significance (P < 0.005) comparing MAC strains with M. tuberculosis H37Rv.

The histopathological analysis of the lungs showed after 2 and 3 weeks of infection with MAC, extensive inflammatory infiltrate constituted by lymphocytes and macrophages located in the alveolar-capillary interstitium, as well as around venules and bronchioles (Fig. 2A and B). At this point during the infection, larger granulomas (12,703 ± 1,000 μm2) were formed than those produced by M. tuberculosis (4,025 ± 670 μm2); 2 weeks later, granulomas induced by MAC (9,215 ± 435 μm2) were similar in size to those in the lungs of M. tuberculosis-infected mice (9,963 ± 650 μm2). During late infection, granulomas progressively declined in number and size, being very few in number and small at day 120 postinfection with either MAC strain (2,844 ± 320 μm2). It is important emphasize that there was little pneumonia in MAC-infected mice (<5%) and that the inflammatory response decreased substantially after 1 month of infection, with only occasional cuffs of lymphocytes around blood vessels and mild hyperplasia of the lymphoid tissue associated with bronchial epithelium observed at day 120 postinfection (Fig. 2D). As shown in Fig. 2D and E, at day 120 there was almost normal histological appearance in the lung of mouse infected with M. colombiense and M. avium. In contrast, M. tuberculosis-infected mice showed progressive pneumonia after 28 days postinfection, reaching its peak at day 120 when 80 ± 10% of the lung surface was affected (Fig. 2F).

Fig 2
  • Open in new tab
  • Download powerpoint
Fig 2

Representative lung histopathology in mice infected by the intratracheal route with MAC strains and M. tuberculosis. (A and B) M. colombiense (A) and M. avium (B) induced extensive inflammatory infiltrate around blood vessels and bronchioles after 21 days of infection. (C) M. tuberculosis infection induced perivascular inflammation with well-formed granulomas (arrow). (D) At day 120 after infection, there is almost normal histological appearance in the lungs of a mouse infected with M. colombiense. (E) Slight inflammation around small blood vessels was observed after 120 days of infection with M. avium. (F) Extensive pneumonia was evidenced after 4 months of infection with M. tuberculosis H37Rv. Hematoxylin and eosin staining; all micrographs, ×200 magnification.

Cytokine gene expression and production in the lungs of infected mice.TNF-α gene expression in mice infected with M. tuberculosis was rapid and higher during early infection and was followed by a progressive decrease during late disease (Fig. 3A). In contrast, whereas infection with M. colombiense induced the highest expression of TNF-α during early infection at days 3 and 7, and this peak was followed by a progressive decrease, in mice infected with M. avium TNF-α showed progressive expression peaking at day 120 (Fig. 3A). Similar kinetics were observed in iNOS gene expression (Fig. 3B). The kinetics of IFN-γ gene expression were similar among the three groups, with higher expression during early infection peaking at day 14, followed by progressive decrease, being higher in mice infected with M. colombiense strain (Fig. 3C). Regarding the expression of anti-inflammatory cytokines, mice infected with M. colombiense showed the highest TGF-β expression from days 3 to 21, whereas animals infected with M. avium exhibited the highest TGF-β expression at days 28 and 60, and both MAC species induced higher TGF-β expression than did M. tuberculosis (Fig. 3D). M. tuberculosis infection induced progressive IL-4 expression, whereas M. colombiense induced lower and stable IL-4 expression, and animals infected with M. avium exhibited higher IL-4 expression during early infection (Fig. 3E). During the first week of infection, M. colombiense induced high expression of IL-10, whereas M. avium and M. tuberculosis induced similar mild expression during late infection at day 120, and both MAC species induced higher expression of IL-10 (Fig. 3F).

Fig 3
  • Open in new tab
  • Download powerpoint
Fig 3

Kinetics of cytokines and iNOS gene expression in mice infected by the intratracheal route. BALB/c mice were infected with M. colombiense (grey), M. avium (white), or M. tuberculosis strain H37Rv (black). Groups of three animals were sacrificed at different time points; gene expression of iNOS and of the indicated cytokines in the lungs was determined by real-time PCR. The results are expressed as means and the standard deviations from three mouse groups. Asterisks represent statistical significance (P < 0.05) of MAC strains compared to M. tuberculosis H37Rv.

Considering that the cytokine gene expression determined by real-time reverse transcription-PCR cannot inform the cellular source and since total tissue homogenates used to isolate RNA may not reflect protein levels, we performed immunohistochemistry and digital quantitative image analysis of lung sections comparing early infection, specifically examining when protective immunity against M. tuberculosis is maximal in this murine model (day 21) and for late disease (day 60) (37). Activated macrophages were the principal source of TNF-α, being 2-fold higher after 21 days of infection in animals infected with M. tuberculosis than with either MAC strain, whereas similar low TNF-α production was seen at day 120 postinfection (Fig. 4). At day 21 postinfection, a trend similar to that seen with TNF-α was observed for IFN-γ production, with lymphocytes being the most common immunostained cells, while at day 60 of infection mice infected with M. tuberculosis showed lower IFN-γ production than at day 21, but it was still significantly higher than in mice infected with either MAC strain. Regarding anti-inflammatory cytokines, low production of both IL-10 and IL-4 was determined at day 21 of infection with either MAC strain or M. tuberculosis, while at day 60 the lungs of mice infected with M. tuberculosis showed 2-fold more IL-10 and IL-4 production than in mice infected with MAC, with lymphocytes being the predominant immunostained cells located in the pneumonic areas in M. tuberculosis infection and in perivascular inflammation in MAC-infected animals (Fig. 4).

Fig 4
  • Open in new tab
  • Download powerpoint
Fig 4

Representative micrographs of cytokine detection (top) and automated morphometry analysis (bottom) from the lungs of infected mice. (A) Numerous IFN-γ immunostained lymphocytes around the bronchial wall and blood vessels after 120 days of infection with M. colombiense. (B) Pneumonic areas after 120 days of infection with M. tuberculosis show abundant IFN-γ immunostained cells. (C) Numerous IL-4 immunoreactive lymphocytes are located in the inflammatory infiltrate around the bronchial wall and blood vessels after 120 days of infection with M. colombiense. (D) Numerous IL-4 immunostained lymphocytes in the pneumonic areas after 120 days of infection with M. tuberculosis strain H37Rv. The bottom panels show quantification of the indicated cytokines by the determination of staining intensity using digital automated morphometry. Results are expressed as means and the standard deviations from three mice per group at days 21 and 120 of infection. Asterisks represent statistical significance (P < 0.05) comparing MAC strains with M. tuberculosis H37Rv.

Survival, histopathology, and bacillary loads in mice infected subcutaneously.Although it is not common, M. avium may penetrate the subcutaneous tissue following traumatic inoculation through the skin (37, 38). To characterize the M. avium and M. colombiense virulence in subcutaneous tissue infection, groups of BALB/c mice (60 per group) were infected in both footpads with either MAC strains or M. tuberculosis H37Rv as comparative control. All of the animals survived after 4 months of infection (data not shown).

Both NTM strains showed progressive increases in the bacillus burden, reaching a peak at day 28 that was higher than in the M. avium infection; this peak was followed by a pronounced decrease until day 120, when the lowest level was detected (Fig. 5A). In contrast, animals infected with M. tuberculosis showed bacillus burdens characterized by a progressive decrease throughout the time points measured, and these burdens were consistently lower than in mice infected with either MAC strain (Fig. 5A). In the regional lymph nodes (inguinal) at any time point measured—except at day 28 postinfection—the bacillus loads were higher in animals infected with MAC than in mice infected with M. tuberculosis. Late during infection, at days 60 and 120, almost 5-fold more CFU were counted in MAC-infected mice than in M. tuberculosis-infected mice, the counts being highest in mice infected with M. avium (Fig. 5B).

Fig 5
  • Open in new tab
  • Download powerpoint
Fig 5

Bacillus loads and representative histopathology in BALB/c mice infected in the footpad subcutaneous tissue. Mice were infected with M. colombiense (grey), M. avium (white), or M. tuberculosis H37Rv (black) and euthanized at different time points after infection, and the footpads (A) and inguinal lymph nodes (B) were used to determine the numbers of CFU. Asterisks represent statistical significance (P < 0.005) comparing MAC strains with M. tuberculosis. Subcutaneous tissues of a mouse after 120 days of infection with M. colombiense (C) and M. avium (D) show the extensive chronic inflammatory infiltrate. (E) Mild inflammation is shown in a mouse 120 days after subcutaneous infection with M. tuberculosis H37Rv (hematoxylin and eosin staining; magnification, ×200).

Extensive and progressive chronic inflammatory infiltrate was seen in the footpad subcutaneous tissue of mice infected with MAC strains at day 60 (data not shown) and 120 when some animals showed focal areas of necrosis and fibrosis, with numerous lymphocytes infiltrating not only the connective tissue but also the muscle and adipose tissues (Fig. 5C and D). In contrast, since the third day of infection, M. tuberculosis induced mild inflammation that consisted of lymphocytes and macrophages spread in the connective tissue, with occasional granulomas seen after 28 days (data not shown). However, the infection did not spread beyond the limb with any of the mycobacterial strains studied. As shown in Fig. 5E, at day 120 of M. tuberculosis infection, scarce chronic inflammatory infiltrate in the connective tissue and around the blood vessels was observed.

Cytokine gene expression and production in the subcutaneous tissues of infected mice.The expression of the proinflammatory cytokines TNF-α and IFN-γ in the subcutaneous tissues of mice infected with M. colombiense was rapid, stable, and highest throughout the course of infection; iNOS exhibited similar kinetics but with fewer transcripts. Subcutaneous infection with M. avium induced low and stable expression of TNF-α, iNOS, and IFN-γ during early infection, similarly to M. colombiense during late infection at days 60 and 120 (Fig. 6A to C). Animals subcutaneously infected with M. tuberculosis exhibited the lowest levels of transcripts encoding TNF-α and iNOS proinflammatory factors (Fig. 6A and B). Although the levels of transcripts for IFN-γ in the footpads of mice infected with the three strains were rather similar throughout the first month, late in the infection (day 120) the levels were higher in footpads infected with M. tuberculosis than in those infected with MAC (Fig. 6C). With regard to the levels of transcripts encoding anti-inflammatory cytokines, during the first month of infection there was similar low expression in animals infected with either strain. At days 60 and 120, there was higher expression, with the levels being similar in the case of TGF-β, and animals infected with M. avium showed the highest IL-10 expression but relatively low numbers of transcripts and similar higher levels for IL-4 in MAC infections (Fig. 6).

Fig 6
  • Open in new tab
  • Download powerpoint
Fig 6

Kinetics of cytokines and iNOS gene expression in mice infected in the footpad subcutaneous tissue. BALB/c mice were infected with M. colombiense (grey), M. avium (white), or M. tuberculosis H37Rv (black). Groups of three animals were sacrificed at different time points; the gene expressions of iNOS and of the indicated cytokines were determined by real-time PCR. The results are expressed as means and the standard deviations from three mice per group. Asterisks represent statistical significance (P < 0.05) comparing MAC strains with M. tuberculosis.

Quantitative immunohistochemistry analysis showed at day 21 postinfection a similar high expression of TNF-α production in mice infected with M. tuberculosis or either MAC strain, with macrophages being the most commonly immunostained cells, while at day 60 of infection animals infected with M. tuberculosis showed significantly lower TNF-α production than did MAC-infected mice, the highest levels being detected in M. avium-infected footpads (Fig. 7). Animals infected with M. avium showed the highest production of IFN-γ at days 21 and 60 of infection, while M. colombiense induced similarly high production: 2-fold higher than M. tuberculosis at day 60 of infection (Fig. 7). Regarding anti-inflammatory cytokines, at day 21, higher production of IL-10 was determined in the footpads of mice infected with M. tuberculosis or M. avium than in the footpads of mice infected with M. colombiense, while at day 120 postinfection, similar low production levels were observed in the footpads of MAC- or M. tuberculosis-infected animals. A comparable trend was observed for IL-4 production (Fig. 7).

Fig 7
  • Open in new tab
  • Download powerpoint
Fig 7

Representative micrographs of cytokine detection (top) and automated morphometry analysis (bottom) from the footpads of infected mice. (A) Numerous TNF-α immunostained cells in the subcutaneous inflammatory infiltrate induced after 120 days of infection with M. avium. (B) In contrast, at the same time point, the subcutaneous inflammation induced by M. tuberculosis shows fewer inflammatory cells and fewer TNF-α immunostained cells. (C) Occasional IL-10 immunoreactive lymphocytes are located in the subcutaneous inflammatory infiltrate after 120 days of infection with M. avium. (D) Scarce IL-10 immunostained lymphocytes in the subcutaneous inflammatory infiltrate after 120 days of infection with M. tuberculosis strain H37Rv. The bottom panels show quantification of the indicated cytokines by the determination of staining intensity using digital automated morphometry. Results are expressed as means and the standard deviations from three mice per group at days 21 and 120 of infection. Asterisks represent statistical significance (P < 0.05) comparing MAC strains with M. tuberculosis.

DISCUSSION

The Mycobacterium avium complex (MAC) consists of nine recognized species and a variety of strains that may be members of undescribed taxa (12, 28, 38–41). MAC can induce four distinct clinical syndromes: pulmonary disease, lymphadenitis, disseminated disease, and skin disease (12). Human infection by MAC is believed to be initiated by the respiratory airways or the intestinal tract. We used intratracheal infection with a high bacillus dose in BALB/c mice in order to reproduce one of the most common infection routes in humans and compared two MAC species and M. tuberculosis H37Rv, which has been extensively studied in this mouse model (32, 33, 35, 37). When BALB/c mice are infected with M. tuberculosis H37Rv, a T helper cell type 1 response is developed that peaks at 2 to 3 weeks, temporarily controlling bacterial growth (33). After this control, bacterial proliferation recommences, accompanied by increasing anti-inflammatory cytokine expression, such as TGF-β, IL-10, and IL-4, and decreasing IFN-γ, TNF-α, and iNOS expression, along with extensive tissue damage and death of the animals (33, 37). Both MAC species induced different disease evolution with total mice survival and scarce pneumonia (<5%) without necrosis or fibrosis. However, both MAC strains induced moderate inflammatory infiltrate around middle-size blood vessels and airways during the first month of infection, as well as granulomas. During the late stage of the infection, the inflammation was almost totally cleared. In addition, mild perivascular inflammatory cuffs and hyperplasia of the lymphoid tissue associated with bronchial mucosa with some intra-alveolar activated macrophages were seen. MAC-infected mice showed an increase in CFU during the first 2 weeks of infection, followed by a progressive decline that was almost undetectable after 4 months of infection. Although the bacillus load kinetics were similar, mice infected with M. avium had higher bacterial burdens than animals infected with M. colombiense, indicating a higher virulence of the former, but both MAC strains were clearly attenuated compared to M. tuberculosis H37Rv. It is interesting that in spite of its attenuation, higher bacillus loads were observed in the blood of mice infected with either MAC species than in M. tuberculosis-infected animals. During the late stage of the infection with MAC, there were also higher bacillus loads in the spleen and mediastinal lymph nodes. It appears that MAC strains disseminate more efficiently than M. tuberculosis H37Rv and, perhaps due to this ability, systemic MAC infections are common in immunodeficient patients.

The cytokine expression profiles in infected lungs were quite different. Intratracheal infection with M. colombiense induced rapid and very high expression of TNF-α during the first and second weeks of infection, followed by a progressive decrease. This TNF-α expression was highest at days 3 and 7 postinfection and exhibited a trend similar to that of iNOS expression. In contrast, M. avium induced low and stable TNF-α expression during the first month of infection, followed by high expression during late infection, peaking at day 120. TNF-α production in M. avium determined by immunohistochemistry, however, was similar to M. colombiense. The iNOS gene expression kinetics were similar to those of TNF-α, which coincided with very low bacillus burdens during late infection. Thus, MAC infection was efficiently controlled, with complete animal survival and minimal tissue damage. TNF-α is one of the most important cytokines produced by macrophages after M. avium recognition and ingestion (42), and the M. avium morphotype and virulence often determine the amount of the cytokine secreted (42, 43). Although some studies show that nitric oxide is relatively ineffective in M. avium removal, since most strains are not susceptible to its toxic effects (44), our results showed that iNOS gene expression kinetics are similar to those of TNF-α, suggesting that nitric oxide may participate in the control of bacillus growth.

Adaptive immunity to M. avium is centered on CD4+ T cells and IFN-γ production. Depletion studies have shown that CD4+ but not CD8+ T lymphocytes are required for adaptive immunity against M. avium (45). Antibody blocking of IFN-γ exacerbates M. avium infection (45), and mice deficient in the expression of this cytokine are more susceptible to the infection (46, 47). Our results showed that the lungs of animals infected with M. avium displayed IFN-γ expression kinetics and protein production similar to that of mice infected with M. tuberculosis, exhibiting higher expression during early infection, followed by a progressive decrease. M. colombiense induced slightly higher IFN-γ production in the earlier stage of the infection rather than later, suggesting that this strain is more efficient at maintaining Th1 responses than is M. avium, an observation that could indicate a higher immunogenicity and lower virulence for M. colombiense than for M. avium. What was not expected was high IFN expression through the course of the infection in BALB/c mice infected with M. tuberculosis. The reason for this finding is unknown. An uninfected control group was not included in the present study that would have allowed us to evaluate this result.

The type 2 response mediated by IL-4, IL-13, IL-10, and TGF-β does not seem to have a significant role in determining susceptibility to infection (48). M. avium infection in C57BL mice does not induce detectable IL-4 responses, and antibody or genetic depletion of IL-10 have little or no impact on the course of M. avium infection (49). Although it was reported that disease was more severe in transgenic mice that overproduce human IL-10 (50), our results suggest that these cytokines should participate in clearing inflammation during the late stage of the infection when MAC bacillus loads are very low. In consequence, this high expression will not have a detrimental effect on bacillus growth control due to their antagonistic effect on Th1 cells. This coincides with previous observations in BALB/c mice that did not develop granuloma necrosis after intravenous infection with virulent M. avium ATCC 25291, and this mouse phenotype was reverted after the genetic disruption of the IL-10 gene (51). In addition, in response to the stress caused by the immune response and hypoxia, the majority of mycobacteria are thought to enter a dormant state in human TB; however, it is not known whether NTM, as MAC members, can develop this state during pulmonary infection. Detection of culturable M. tuberculosis from latently infected individuals is extremely difficult. Our results in this model of pulmonary infection in BALB/c mice suggest that the MAC species used here (M. avium and M. colombiense) developed a viable but not culturable state (52) with mild levels of pro- and anti-inflammatory cytokines (TNF-α versus IL-10) characterized by minimal pulmonary inflammation and very low bacillus burdens. Additional experiments are needed to investigate this hypothesis.

MAC can also enter the host by the intradermal route through cuts and skin punctures (53, 54). Experimental work showed that intradermal bacillus administration resulted in infection of cervical and/or axillary lymph nodes in both BALB/c and nude mice, suggesting that skin lesions may also be responsible for the cervical lymphadenitis seen in humans (53). Our results confirmed and extended these findings by the demonstration that subcutaneous infection in the footpads of BALB/c mice induced local bacillus growth. This growth was efficiently controlled after 4 months of infection and was able to disseminate to local lymph nodes (inguinal) and shown to be higher in mice infected with M. avium. One significant difference with pulmonary infection despite low bacillus loads was the extensive and constant inflammation with fibrosis produced by MAC infection in the subcutaneous tissue. This tissue response corresponds with the high and stable expression and production of TNF-α and IFN-γ during the later stage of infection with MAC along with the production of relatively low anti-inflammatory cytokines. Although MAC induced a high expression of TNF-α and IFN-γ during late subcutaneous infection, iNOS expression was slightly higher. Nitric oxide is an inhibitory factor in the production of fibrosis, as shown in iNOS-deficient mice infected with mycobacteria that developed more fibrosis (55). Thus, the fibrosis observed in the subcutaneous tissue during the late stage of the MAC infection in BALB/c mice could be influenced by the low expression of iNOS.

Few mycobacterial species, most of which are pathogenic for humans, produce a unique array of complex cell wall-associated lipids, such as phthiocerol dimycocerosates (PDIMs) and phenolglycolipids (PGLs), two groups of molecules shown to be important virulence factors (56, 57). Experimental studies demonstrated that M. tuberculosis strains deficient in the production or surface localization of PDIMs are markedly attenuated for growth in the lungs of intravenously or intranasally infected mice (58–60), and both PDIMs and PGLs are required for full virulence of M. marinum in the zebrafish model (61). Members of M. tuberculosis complex also produce p-hydroxybenzoic acid derivatives (p-HBADs), which are precursors of PGL biosynthesis (62). Mutants of M. tuberculosis that lack production of some or all forms of p-HBADs were shown to induce histological differences in lung tissue of infected BALB/c mice with extensive and diffuse inflammation (63). These M. tuberculosis mutants also induce an increased secretion of the proinflammatory cytokines TNF-α, IL-6, and IL-12 compared to the M. tuberculosis strain Mt103 (63). These studies could indicate that while PGL and PDIM are associated with virulence, p-HBAD is associated with tissue damage. The biosynthesis of PDIM/PGL/p-HBAD is a very complex pathway that involves more than 15 enzymatic steps and more than 27 genes, most clustered on a 70-kb region of the chromosome (56, 64), and MAC members lack several important genes necessary for the biosynthesis of these lipid molecules (65–67; see also the Virulence Factors of Pathogenic Bacteria database [http://www.mgc.ac.cn/cgi-bin/VFs/compvfs.cgi?Genus=Mycobacterium]) (Fig. 8). We hypothesized that MAC members and M. tuberculosis have different pathogenicities and trigger different immune responses and inflammation as a result of differences in their cell envelopes. Thus, in the murine model of infection with MAC strains, the low virulence could be associated with the lack of production of PDIMs and/or PGLs, and the high chronic inflammation could be associated with the lack of production of p-HBADs.

Fig 8
  • Open in new tab
  • Download powerpoint
Fig 8

Comparative genomics of the PDIM/PGL/p-HBAD locus between MAC species and M. tuberculosis H37Rv. Many genomes of the MAC members (i.e., M. colombiense CECT 3035, M. intracellulare ATCC 13950, M. indicus pranii MTCC 9506, M. avium 104, and M. avium subsp. paratuberculosis k-10) lack several important genes necessary for the biosynthesis of these lipid molecules.

In conclusion, MAC strains differ in their level of virulence and type of immune response. M. colombiense and M. avium demonstrate low virulence in BALB/c mice infected by the intratracheal route. Infection in subcutaneous tissue by either MAC strain was also efficiently controlled, but they each induced high expression of proinflammatory cytokines during the later stage of the infection and relatively low production of anti-inflammatory cytokines, producing extensive and constant inflammation. In addition to the mycobacterial antigenic constitution and the genetic background of mice, the site of infection is important in the type of evoked immune response.

ACKNOWLEDGMENTS

This study was supported in part by the Intramural Research Program of the National Institutes of Health, National Library of Medicine, National Center for Biotechnology Information, and CONACyT (grant 84456). M.G.-P. was supported by the National University of Colombia (Convocatoria Apoyo de la DIB a Tesis de Investigacion en Posgrados–Quinto Corte; Proyecto 15129).

We thank Jian Yang (Institute of Pathogen Biology, CAMS&PUMC) for the analysis of PDIM/PGL locus in Mycobacterium genomes.

FOOTNOTES

    • Received 1 February 2013.
    • Returned for modification 18 March 2013.
    • Accepted 29 July 2013.
    • Accepted manuscript posted online 19 August 2013.
  • Copyright © 2013, American Society for Microbiology. All Rights Reserved.

REFERENCES

  1. 1.↵
    1. Euzéby JP
    . 1997. List of bacterial names with standing in nomenclature: a folder available on the internet. Int. J. Syst. Bacteriol. 47:590–592.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Euzéby JP
    . 2013. List of prokaryotic names with standing in nomenclature, genus Mycobacterium. http://www.bacterio.cict.fr/m/mycobacterium.html.
  3. 3.↵
    1. Ducati RG,
    2. Ruffino-Netto A,
    3. Basso LA,
    4. Santos DS
    . 2006. The resumption of consumption: a review on tuberculosis. Mem. Inst. Oswaldo Cruz 101:697–714.
    OpenUrlPubMed
  4. 4.↵
    World Health Organization. 2013. The top 10 causes of death: fact sheet 310. World Health Organization, Geneva, Switzerland. http://www.who.int/mediacentre/factsheets/fs310/en/index.html.
  5. 5.↵
    World Health Organization. 2013. Global tuberculosis report 2012. World Health Organization, Geneva, Switzerland. http://apps.who.int/iris/bitstream/10665/75938/1/9789241564502_eng.pdf.
  6. 6.↵
    1. Inderlied CB,
    2. Kemper CA,
    3. Bermudez LE
    . 1993. The Mycobacterium avium complex. Clin. Microbiol. Rev. 6:266–310.
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    1. McGrath EE,
    2. McCabe J,
    3. Anderson PB
    . 2008. Guidelines on the diagnosis and treatment of pulmonary non-tuberculous mycobacteria infection. Int. J. Clin. Pract. 62:1947–1955.
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. Marras TK,
    2. Daley CL
    . 2002. Epidemiology of human pulmonary infection with nontuberculous mycobacteria. Clin. Chest Med. 23:553–567.
    OpenUrlCrossRefPubMedWeb of Science
  9. 9.↵
    1. Marras TK,
    2. Chedore P,
    3. Ying AM,
    4. Jamieson F
    . 2007. Isolation prevalence of pulmonary non-tuberculous mycobacteria in Ontario, 1997–2003. Thorax 62:661–666.
    OpenUrlAbstract/FREE Full Text
  10. 10.↵
    1. Khan K,
    2. Wang J,
    3. Marras TK
    . 2007. Nontuberculous mycobacterial sensitization in the United States: national trends over three decades. Am. J. Respir. Crit. Care Med. 176:306–313.
    OpenUrlCrossRefPubMedWeb of Science
  11. 11.↵
    1. Henry MT,
    2. Inamdar L,
    3. O'Riordain D,
    4. Schweiger M,
    5. Watson JP
    . 2004. Nontuberculous mycobacteria in non-HIV patients: epidemiology, treatment, and response. Eur. Respir. J. 23:741–746.
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    1. Griffith DE,
    2. Aksamit T,
    3. Brown-Elliott BA,
    4. Catanzaro A,
    5. Daley C,
    6. Gordin F,
    7. Holland SM,
    8. Horsburgh R,
    9. Huitt G,
    10. Iademarco MF,
    11. Iseman M,
    12. Olivier K,
    13. Ruoss S,
    14. von Reyn CF,
    15. Wallace RJ Jr,
    16. Winthrop K
    . 2007. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am. J. Respir. Crit. Care Med. 175:367–416.
    OpenUrlCrossRefPubMedWeb of Science
  13. 13.↵
    1. Behr MA
    . 2008. Mycobacterium du jour: what's on tomorrow's menu? Microbes Infect. 10:968–972.
    OpenUrlCrossRefPubMed
  14. 14.↵
    1. Parrish SC,
    2. Myers J,
    3. Lazarus A
    . 2008. Nontuberculous mycobacterial pulmonary infections in non-HIV patients. Postgrad. Med. 120:78–86.
    OpenUrlCrossRefPubMed
  15. 15.↵
    1. Grubek-Jaworska H,
    2. Walkiewicz R,
    3. Safianowska A,
    4. Nowacka-Mazurek M,
    5. Krenke R,
    6. Przybylowski T,
    7. Chazan R
    . 2009. Nontuberculous mycobacterial infections among patients suspected of pulmonary tuberculosis. Eur. J. Clin. Microbiol. Infect. Dis. 28:739–744.
    OpenUrlCrossRefPubMed
  16. 16.↵
    1. Tabarsi P,
    2. Baghaei P,
    3. Farnia P,
    4. Mansouri N,
    5. Chitsaz E,
    6. Sheikholeslam F,
    7. Marjani M,
    8. Rouhani N,
    9. Mirsaeidi M,
    10. Alipanah N,
    11. Amiri M,
    12. Masjedi MR,
    13. Mansouri D
    . 2009. Nontuberculous mycobacteria among patients who are suspected for multidrug-resistant tuberculosis-need for earlier identification of nontuberculosis mycobacteria. Am. J. Med. Sci. 337:182–184.
    OpenUrlCrossRefPubMed
  17. 17.↵
    1. Zhang ZY,
    2. Sun ZQ,
    3. Wang ZL,
    4. Hu HR,
    5. Wen ZL,
    6. Song YZ,
    7. Zhao JW,
    8. Wang HH,
    9. Guo XK,
    10. Zhang SL
    . 2013. Identification and pathogenicity analysis of a novel non-tuberculous Mycobacterium clinical isolate with nine-antibiotic resistance. Clin. Microbiol. Infect. 19:91–96.
    OpenUrlCrossRefPubMed
  18. 18.↵
    1. Haverkort F
    . 2003. National atypical mycobacteria survey, 2000. Commun. Dis. Intell. 27:180–189.
    OpenUrlPubMed
  19. 19.↵
    1. Freeman J,
    2. Morris A,
    3. Blackmore T,
    4. Hammer D,
    5. Munroe S,
    6. McKnight L
    . 2007. Incidence of nontuberculous mycobacterial disease in New Zealand, 2004. N. Z. Med. J. 120:U2580.
    OpenUrlPubMed
  20. 20.↵
    1. Murcia-Aranguren MI,
    2. Gomez-Marin JE,
    3. Alvarado FS,
    4. Bustillo JG,
    5. de Mendivelson E,
    6. Gomez B,
    7. Leon CI,
    8. Triana WA,
    9. Vargas EA,
    10. Rodriguez E
    . 2001. Frequency of tuberculous and non-tuberculous mycobacteria in HIV-infected patients from Bogota, Colombia. BMC Infect. Dis. 1:21. doi:10.1186/1471-2334-1-21.
    OpenUrlCrossRefPubMed
  21. 21.↵
    1. Chatterjee D,
    2. Khoo KH
    . 2001. The surface glycopeptidolipids of mycobacteria: structures and biological properties. Cell Mol. Life Sci. 58:2018–2042.
    OpenUrlCrossRefPubMedWeb of Science
  22. 22.↵
    1. Rocco JM,
    2. Irani VR
    . 2011. Mycobacterium avium and modulation of the host macrophage immune mechanisms. Int. J. Tuberc. Lung Dis. 15:447–452.
    OpenUrlCrossRefPubMed
  23. 23.↵
    World Health Organization. 2013. Guidelines on standard operating procedures for laboratory diagnosis of HIV-opportunistic infections. World Health Organization Regional Office for South-East Asia, WHO, SEARO, New Delhi, India. http://203.90.70.117/PDS_DOCS/B0189.pdf.
  24. 24.↵
    1. Ostroff SM,
    2. Spiegel RA,
    3. Feinberg J,
    4. Benson CA,
    5. Horsburgh CR Jr
    . 1995. Preventing disseminated Mycobacterium avium complex disease in patients infected with human immunodeficiency virus. Clin. Infect. Dis. 21(Suppl 1):S72–S76.
    OpenUrlCrossRefPubMed
  25. 25.↵
    1. Primm TP,
    2. Lucero CA,
    3. Falkinham JO III
    . 2004. Health impacts of environmental mycobacteria. Clin. Microbiol. Rev. 17:98–106.
    OpenUrlAbstract/FREE Full Text
  26. 26.↵
    1. Field SK,
    2. Cowie RL
    . 2006. Lung disease due to the more common nontuberculous mycobacteria. Chest 129:1653–1672.
    OpenUrlCrossRefPubMedWeb of Science
  27. 27.↵
    1. Benson C
    . 1994. Disseminated Mycobacterium avium complex disease in patients with AIDS. AIDS Res. Hum. Retrovir. 10:913–916.
    OpenUrlPubMed
  28. 28.↵
    1. Murcia MI,
    2. Tortoli E,
    3. Menendez MC,
    4. Palenque E,
    5. Garcia MJ
    . 2006. Mycobacterium colombiense sp. nov., a novel member of the Mycobacterium avium complex, and description of MAC-X as a new ITS genetic variant. Int. J. Syst. Evol. Microbiol. 56:2049–2054.
    OpenUrlCrossRefPubMedWeb of Science
  29. 29.↵
    1. Vuorenmaa K,
    2. Ben Salah I,
    3. Barlogis V,
    4. Chambost H,
    5. Drancourt M
    . 2009. Mycobacterium colombiense and pseudotuberculous lymphadenopathy. Emerg. Infect. Dis. 15:619–620.
    OpenUrlCrossRefPubMed
  30. 30.↵
    1. Esparcia O,
    2. Navarro F,
    3. Quer M,
    4. Coll P
    . 2008. Lymphadenopathy caused by Mycobacterium colombiense. J. Clin. Microbiol. 46:1885–1887.
    OpenUrlAbstract/FREE Full Text
  31. 31.↵
    1. Cohen-Bacrie S,
    2. David M,
    3. Stremler N,
    4. Dubus J-C,
    5. Rolain J-M,
    6. Drancourt M
    . 2011. Mycobacterium chimaera pulmonary infection complicating cystic fibrosis: a case report. J. Med. Case Rep. 5:473.
    OpenUrlCrossRefPubMed
  32. 32.↵
    1. Lopez B,
    2. Aguilar D,
    3. Orozco H,
    4. Burger M,
    5. Espitia C,
    6. Ritacco V,
    7. Barrera L,
    8. Kremer K,
    9. Hernandez-Pando R,
    10. Huygen K,
    11. van Soolingen D
    . 2003. A marked difference in pathogenesis and immune response induced by different Mycobacterium tuberculosis genotypes. Clin. Exp. Immunol. 133:30–37.
    OpenUrlCrossRefPubMedWeb of Science
  33. 33.↵
    1. Hernandez-Pando R,
    2. Orozcoe H,
    3. Sampieri A,
    4. Pavon L,
    5. Velasquillo C,
    6. Larriva-Sahd J,
    7. Alcocer JM,
    8. Madrid MV
    . 1996. Correlation between the kinetics of Th1, Th2 cells and pathology in a murine model of experimental pulmonary tuberculosis. Immunology 89:26–33.
    OpenUrlPubMedWeb of Science
  34. 34.↵
    1. Mustafa T,
    2. Phyu S,
    3. Nilsen R,
    4. Jonsson R,
    5. Bjune G
    . 1999. A mouse model for slowly progressive primary tuberculosis. Scand. J. Immunol. 50:127–136.
    OpenUrlCrossRefPubMedWeb of Science
  35. 35.↵
    1. Leong FJ,
    2. Dartois V,
    3. Dick T
    . 2011. A color atlas of comparative pathology of pulmonary tuberculosis. CRC Press/Taylor & Francis Group, London, United Kingdom.
  36. 36.↵
    1. Ortiz RH,
    2. Leon DA,
    3. Estevez HO,
    4. Martin A,
    5. Herrera JL,
    6. Romo LF,
    7. Portaels F,
    8. Pando RH
    . 2009. Differences in virulence and immune response induced in a murine model by isolates of Mycobacterium ulcerans from different geographic areas. Clin. Exp. Immunol. 157:271–281.
    OpenUrlCrossRefPubMed
  37. 37.↵
    1. Marquina-Castillo B,
    2. Garcia-Garcia L,
    3. Ponce-de-Leon A,
    4. Jimenez-Corona ME,
    5. Bobadilla-Del Valle M,
    6. Cano-Arellano B,
    7. Canizales-Quintero S,
    8. Martinez-Gamboa A,
    9. Kato-Maeda M,
    10. Robertson B,
    11. Young D,
    12. Small P,
    13. Schoolnik G,
    14. Sifuentes-Osornio J,
    15. Hernandez-Pando R
    . 2009. Virulence, immunopathology, and transmissibility of selected strains of Mycobacterium tuberculosis in a murine model. Immunology 128:123–133.
    OpenUrlCrossRefPubMed
  38. 38.↵
    1. Ben Salah I,
    2. Cayrou C,
    3. Raoult D,
    4. Drancourt M
    . 2009. Mycobacterium marseillense sp. nov., Mycobacterium timonense sp. nov. and Mycobacterium bouchedurhonense sp. nov., members of the Mycobacterium avium complex. Int. J. Syst. Evol. Microbiol. 59:2803–2808.
    OpenUrlCrossRefPubMed
  39. 39.↵
    1. van Ingen J,
    2. Boeree MJ,
    3. Kosters K,
    4. Wieland A,
    5. Tortoli E,
    6. Dekhuijzen PN,
    7. van Soolingen D
    . 2009. Proposal to elevate Mycobacterium avium complex ITS sequevar MAC-Q to Mycobacterium vulneris sp. nov. Int. J. Syst. Evol. Microbiol. 59:2277–2282.
    OpenUrlCrossRef
  40. 40.↵
    1. Cayrou C,
    2. Turenne C,
    3. Behr MA,
    4. Drancourt M
    . 2010. Genotyping of Mycobacterium avium complex organisms using multispacer sequence typing. Microbiology 156:687–694.
    OpenUrlCrossRefPubMedWeb of Science
  41. 41.↵
    1. Saini V,
    2. Raghuvanshi S,
    3. Talwar GP,
    4. Ahmed N,
    5. Khurana JP,
    6. Hasnain SE,
    7. Tyagi AK,
    8. Tyagi AK
    . 2009. Polyphasic taxonomic analysis establishes Mycobacterium indicus pranii as a distinct species. PLoS One 4:e6263. doi:10.1371/journal.pone.0006263.
    OpenUrlCrossRefPubMed
  42. 42.↵
    1. Furney SK,
    2. Skinner PS,
    3. Roberts AD,
    4. Appelberg R,
    5. Orme IM
    . 1992. Capacity of Mycobacterium avium isolates to grow well or poorly in murine macrophages resides in their ability to induce secretion of tumor necrosis factor. Infect. Immun. 60:4410–4413.
    OpenUrlAbstract/FREE Full Text
  43. 43.↵
    1. Sarmento AM,
    2. Appelberg R
    . 1995. Relationship between virulence of Mycobacterium avium strains and induction of tumor necrosis factor alpha production in infected mice and in in vitro-cultured mouse macrophages. Infect. Immun. 63:3759–3764.
    OpenUrlAbstract/FREE Full Text
  44. 44.↵
    1. McGarvey J,
    2. Bermudez LE
    . 2002. Pathogenesis of nontuberculous mycobacteria infections. Clin. Chest Med. 23:569–583.
    OpenUrlCrossRefPubMedWeb of Science
  45. 45.↵
    1. Saunders BM,
    2. Cheers C
    . 1995. Inflammatory response following intranasal infection with Mycobacterium avium complex: role of T-cell subsets and gamma interferon. Infect. Immun. 63:2282–2287.
    OpenUrlAbstract/FREE Full Text
  46. 46.↵
    1. Doherty TM,
    2. Sher A
    . 1997. Defects in cell-mediated immunity affect chronic, but not innate, resistance of mice to Mycobacterium avium infection. J. Immunol. 158:4822–4831.
    OpenUrlAbstract
  47. 47.↵
    1. Silva RA,
    2. Florido M,
    3. Appelberg R
    . 2001. Interleukin-12 primes CD4+ T cells for interferon-gamma production and protective immunity during Mycobacterium avium infection. Immunology 103:368–374.
    OpenUrlCrossRefPubMedWeb of Science
  48. 48.↵
    1. Appelberg R
    . 2006. Pathogenesis of Mycobacterium avium infection: typical responses to an atypical Mycobacterium? Immunol. Res. 35:179–190.
    OpenUrlCrossRefPubMed
  49. 49.↵
    1. Roach DR,
    2. Martin E,
    3. Bean AG,
    4. Rennick DM,
    5. Briscoe H,
    6. Britton WJ
    . 2001. Endogenous inhibition of antimycobacterial immunity by IL-10 varies between mycobacterial species. Scand. J. Immunol. 54:163–170.
    OpenUrlCrossRefPubMed
  50. 50.↵
    1. Feng CG,
    2. Kullberg MC,
    3. Jankovic D,
    4. Cheever AW,
    5. Caspar P,
    6. Coffman RL,
    7. Sher A
    . 2002. Transgenic mice expressing human interleukin-10 in the antigen-presenting cell compartment show increased susceptibility to infection with Mycobacterium avium associated with decreased macrophage effector function and apoptosis. Infect. Immun. 70:6672–6679.
    OpenUrlAbstract/FREE Full Text
  51. 51.↵
    1. Florido M,
    2. Appelberg R
    . 2006. Genetic control of immune-mediated necrosis of Mycobacterium avium granulomas. Immunology 118:122–130.
    OpenUrlCrossRefPubMed
  52. 52.↵
    1. Chao MC,
    2. Rubin EJ
    . 2010. Letting sleeping dos lie: does dormancy play a role in tuberculosis? Annu. Rev. Microbiol. 64:293–311.
    OpenUrlCrossRefPubMedWeb of Science
  53. 53.↵
    1. Smith MJ,
    2. Grange JM
    . 1989. Deep tissue infections due to environmental bacteria, p 511–564. In Ratledge C, Stanford J, Grange MJ (ed), The biology of the mycobacteria, vol 3. Academic Press, London, United Kingdom.
    OpenUrl
  54. 54.↵
    1. Noguchi H,
    2. Hiruma M,
    3. Kawada A,
    4. Fujimoto N,
    5. Fujioka A,
    6. Ishibashi A
    . 1998. A pediatric case of atypical Mycobacterium avium infection of the skin. J. Dermatol. 25:384–390.
    OpenUrlPubMed
  55. 55.↵
    1. Lousada S,
    2. Florido M,
    3. Appelberg R
    . 2006. Regulation of granuloma fibrosis by nitric oxide during Mycobacterium avium experimental infection. Int. J. Exp. Pathol. 87:307–315.
    OpenUrlCrossRefPubMed
  56. 56.↵
    1. Onwueme KC,
    2. Vos CJ,
    3. Zurita J,
    4. Ferreras JA,
    5. Quadri LE
    . 2005. The dimycocerosate ester polyketide virulence factors of mycobacteria. Prog. Lipid Res. 44:259–302.
    OpenUrlCrossRefPubMedWeb of Science
  57. 57.↵
    1. Daffe M,
    2. Laneelle MA
    . 1988. Distribution of phthiocerol diester, phenolic mycosides and related compounds in mycobacteria. J. Gen. Microbiol. 134:2049–2055.
    OpenUrlCrossRefPubMedWeb of Science
  58. 58.↵
    1. Cox JS,
    2. Chen B,
    3. McNeil M,
    4. Jacobs WR Jr
    . 1999. Complex lipid determines tissue-specific replication of Mycobacterium tuberculosis in mice. Nature 402:79–83.
    OpenUrlCrossRefPubMedWeb of Science
  59. 59.↵
    1. Camacho LR,
    2. Ensergueix D,
    3. Perez E,
    4. Gicquel B,
    5. Guilhot C
    . 1999. Identification of a virulence gene cluster of Mycobacterium tuberculosis by signature-tagged transposon mutagenesis. Mol. Microbiol. 34:257–267.
    OpenUrlCrossRefPubMedWeb of Science
  60. 60.↵
    1. Rousseau C,
    2. Winter N,
    3. Pivert E,
    4. Bordat Y,
    5. Neyrolles O,
    6. Ave P,
    7. Huerre M,
    8. Gicquel B,
    9. Jackson M
    . 2004. Production of phthiocerol dimycocerosates protects Mycobacterium tuberculosis from the cidal activity of reactive nitrogen intermediates produced by macrophages and modulates the early immune response to infection. Cell. Microbiol. 6:277–287.
    OpenUrlCrossRefPubMedWeb of Science
  61. 61.↵
    1. Yu J,
    2. Tran V,
    3. Li M,
    4. Huang X,
    5. Niu C,
    6. Wang D,
    7. Zhu J,
    8. Wang J,
    9. Gao Q,
    10. Liu J
    . 2012. Both phthiocerol dimycocerosates and phenolic glycolipids are required for virulence of Mycobacterium marinum. Infect. Immun. 80:1381–1389.
    OpenUrlAbstract/FREE Full Text
  62. 62.↵
    1. Constant P,
    2. Perez E,
    3. Malaga W,
    4. Laneelle MA,
    5. Saurel O,
    6. Daffe M,
    7. Guilhot C
    . 2002. Role of the pks15/1 gene in the biosynthesis of phenolglycolipids in the Mycobacterium tuberculosis complex: evidence that all strains synthesize glycosylated p-hydroxybenzoic methyl esters and that strains devoid of phenolglycolipids harbor a frameshift mutation in the pks15/1 gene. J. Biol. Chem. 277:38148–38158.
    OpenUrlAbstract/FREE Full Text
  63. 63.↵
    1. Stadthagen G,
    2. Jackson M,
    3. Charles P,
    4. Boudou F,
    5. Barilone N,
    6. Huerre M,
    7. Constant P,
    8. Liav A,
    9. Bottova I,
    10. Nigou J,
    11. Brando T,
    12. Puzo G,
    13. Daffe M,
    14. Benjamin P,
    15. Coade S,
    16. Buxton RS,
    17. Tascon RE,
    18. Rae A,
    19. Robertson BD,
    20. Lowrie DB,
    21. Young DB,
    22. Gicquel B,
    23. Griffin R
    . 2006. Comparative investigation of the pathogenicity of three Mycobacterium tuberculosis mutants defective in the synthesis of p-hydroxybenzoic acid derivatives. Microbes Infect. 8:2245–2253.
    OpenUrlCrossRefPubMed
  64. 64.↵
    1. Perez E,
    2. Constant P,
    3. Laval F,
    4. Lemassu A,
    5. Laneelle MA,
    6. Daffe M,
    7. Guilhot C
    . 2004. Molecular dissection of the role of two methyltransferases in the biosynthesis of phenolglycolipids and phthiocerol dimycoserosate in the Mycobacterium tuberculosis complex. J. Biol. Chem. 279:42584–42592.
    OpenUrlAbstract/FREE Full Text
  65. 65.↵
    1. Chen L,
    2. Yang J,
    3. Yu J,
    4. Yao Z,
    5. Sun L,
    6. Shen Y,
    7. Jin Q
    . 2005. VFDB: a reference database for bacterial virulence factors. Nucleic Acids Res. 33:D325–D328.
    OpenUrlCrossRefPubMedWeb of Science
  66. 66.↵
    1. Yang J,
    2. Chen L,
    3. Sun L,
    4. Yu J,
    5. Jin Q
    . 2008. VFDB 2008 release: an enhanced web-based resource for comparative pathogenomics. Nucleic Acids Res. 36:D539–D542.
    OpenUrlCrossRefPubMedWeb of Science
  67. 67.↵
    1. Chen L,
    2. Xiong Z,
    3. Sun L,
    4. Yang J,
    5. Jin Q
    . 2012. VFDB 2012 update: toward the genetic diversity and molecular evolution of bacterial virulence factors. Nucleic Acids Res. 40:D641–D645.
    OpenUrlCrossRefPubMedWeb of Science
View Abstract
PreviousNext
Back to top
Download PDF
Citation Tools
Virulence and Immune Response Induced by Mycobacterium avium Complex Strains in a Model of Progressive Pulmonary Tuberculosis and Subcutaneous Infection in BALB/c Mice
Mónica González-Pérez, Leonardo Mariño-Ramírez, Carlos Alberto Parra-López, Martha Isabel Murcia, Brenda Marquina, Dulce Mata-Espinoza, Yadira Rodriguez-Míguez, Guillermina J. Baay-Guzman, Sara Huerta-Yepez, Rogelio Hernandez-Pando
Infection and Immunity Oct 2013, 81 (11) 4001-4012; DOI: 10.1128/IAI.00150-13

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Infection and Immunity article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Virulence and Immune Response Induced by Mycobacterium avium Complex Strains in a Model of Progressive Pulmonary Tuberculosis and Subcutaneous Infection in BALB/c Mice
(Your Name) has forwarded a page to you from Infection and Immunity
(Your Name) thought you would be interested in this article in Infection and Immunity.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Virulence and Immune Response Induced by Mycobacterium avium Complex Strains in a Model of Progressive Pulmonary Tuberculosis and Subcutaneous Infection in BALB/c Mice
Mónica González-Pérez, Leonardo Mariño-Ramírez, Carlos Alberto Parra-López, Martha Isabel Murcia, Brenda Marquina, Dulce Mata-Espinoza, Yadira Rodriguez-Míguez, Guillermina J. Baay-Guzman, Sara Huerta-Yepez, Rogelio Hernandez-Pando
Infection and Immunity Oct 2013, 81 (11) 4001-4012; DOI: 10.1128/IAI.00150-13
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • INTRODUCTION
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

About

  • About IAI
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #IAIjournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0019-9567; Online ISSN: 1098-5522